PBA
Paradigm Biocapital Advisors’s Edgewise Therapeutics EWTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.5M | Buy |
6,142,344
+1,747,788
| +40% | +$22.9M | 3.44% | 8 |
|
|
2025
Q1 | $96.7M | Sell |
4,394,556
-99,373
| -2% | -$2.19M | 4.43% | 7 |
|
|
2024
Q4 | $120M | Buy |
4,493,929
+1,704,757
| +61% | +$45.5M | 4.17% | 7 |
|
|
2024
Q3 | $74.4M | Buy |
2,789,172
+463,723
| +20% | +$12.4M | 2.52% | 10 |
|
|
2024
Q2 | $41.9M | Sell |
2,325,449
-120,924
| -5% | -$2.18M | 1.6% | 20 |
|
|
2024
Q1 | $44.6M | Buy |
+2,446,373
| New | +$44.6M | 1.57% | 21 |
|